Search

everythinglearnresearchcommunity

for

Search:↓

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Low-Level Light Therapy (LLLT) is a safe and effective method for skin rejuvenation, acne treatment, wound healing, body contouring, and hair growth, but more well-designed trials are needed for confirmation.

Finasteride effectively treats male hair loss, improving growth and density.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Hair transplants look natural, but the best method is debated, and PRP shows promise for hair regrowth.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Artificial skin is improving wound healing and shows potential for treating different types of wounds.

A new gene mutation linked to a skin condition was found in a Spanish family.

Finasteride helps hair loss patients' quality of life.

Caffeine-based liquid 0.2% is as effective as minoxidil 5% for treating male hair loss.

17α-Estradiol solution safely improves hair density and thickness in female pattern hair loss.

Acceptance reduces hair loss distress and medical consultations; coping mechanisms increase them.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Thioglycolate lotions are the most popular method for permanent waving and hair straightening.

Metformin helped improve the quality of life for Chinese women with PCOS, especially in physical health and symptoms like infertility, acne, and hair loss.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

New gel formulas without ethanol and propylene glycol, containing a minoxidil-methyl-β-cyclodextrin complex, have been created for treating hair loss.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Hair transplantation has improved with techniques that increase graft survival and patient satisfaction for more natural results.

Oral minoxidil improves hair density in women with androgenetic alopecia, with mild side effects.

Finasteride side effects in young men may be linked to specific gene variations.

Alopecia areata and androgenetic alopecia affect quality of life similarly.

Certain MC4R gene variants are linked to higher BMI in obese women with PCOS but do not cause PCOS.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.